candesartan and leptin

candesartan has been researched along with leptin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Blum, WF; Hauner, H; Skurk, T; van Harmelen, V1
Jöhren, O; Markert, A; Müller-Fielitz, H; Pahlke, F; Raasch, W; Wittmershaus, C1
Hass, A; Mashavi, M; Oz, H; Shargorodsky, M1
Jöhren, O; Mildner, M; Müller-Fielitz, H; Raasch, W; Steckelings, M; Stölting, I1
Cartwright, JE; Dechend, R; Desoye, G; El-Heliebi, A; Fischer, C; Forstner, D; Gauster, M; Geisberger, S; Herse, F; Huppertz, B; Kollmann, M; Kroneis, T; Nonn, O; Pecks, U; Staff, AC; Stern, C; Sugulle, M; Thilaganathan, B; Wadsack, C; Whitley, GS1

Trials

1 trial(s) available for candesartan and leptin

ArticleYear
Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients.
    Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:10

    Topics: Adipokines; Adiponectin; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Physiological Phenomena; Female; Homeostasis; Humans; Hypertension; Leptin; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles

2014

Other Studies

4 other study(ies) available for candesartan and leptin

ArticleYear
Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway.
    Obesity research, 2005, Volume: 13, Issue:6

    Topics: Adipocytes; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Butadienes; Cells, Cultured; Chromans; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Female; Fibrinolytic Agents; Humans; Leptin; MAP Kinase Signaling System; Nitriles; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidinediones; Troglitazone

2005
Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Eating; Hypothalamus; Leptin; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Zucker; Receptors, Leptin; RNA, Messenger; Signal Transduction; Tetrazoles; Weight Loss

2011
Glucagon increase after chronic AT
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Glucagon; Hypoglycemic Agents; Islets of Langerhans; Leptin; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Time Factors; Up-Regulation

2017
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
    Hypertension (Dallas, Tex. : 1979), 2021, 05-05, Volume: 77, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Benzimidazoles; Biphenyl Compounds; Female; Humans; Leptin; Leucyl Aminopeptidase; Placenta; Pre-Eclampsia; Pregnancy; Renin-Angiotensin System; Tetrazoles; Uterine Artery; Vascular Resistance

2021